Latest US IPOs in 2026: Comapnies that have gone public

The Dangote Petroleum Refinery IPO has been one of Nigeria's biggest investment conversations this year. Its public offer opened on the Nigerian Exchange (NGX) on September 14, with 4.1 billion shares priced at ₦525 each.

But Dangote isn't the only major listing worth watching. The US stock market has been busy in 2026 too, with companies across artificial intelligence, quantum computing, healthcare, energy, restaurants, and technology going public. Some are established businesses entering the public markets after years of private growth, while others are younger companies raising capital to fund their next stage of development.

If you're looking for the latest IPOs in 2026, this guide covers notable companies that have gone public in the US this year, what they do, their stock tickers, and how their shares have performed since their IPOs. We also look at two of the most anticipated listings that could come next: OpenAI and Anthropic.

New to IPOs? Read our guide on how IPO investing works to learn more. Prices and performance figures in this article are based on closing prices as of September 30, 2026.

10 Latest US IPOs in 2026

Hundreds of IPOs have occurred on US exchanges in 2026, though that figure includes SPACs and other types of listings. The companies below focus on notable operating businesses that completed traditional public offerings this year.

1. SpaceX (SPCX)

What it does: SpaceX develops rockets, spacecraft, satellite communications and AI infrastructure through businesses including Starlink and xAI.

IPO date: 12 June 2026; Exchange: Nasdaq; IPO price: $135

SpaceX's public debut was one of the biggest IPOs in market history. The company priced its IPO at $135 per share and began trading on Nasdaq under the ticker SPCX in June.

Its business spans commercial space launches, spacecraft, satellite internet through Starlink and, since its acquisition of xAI in February 2026, artificial intelligence. For investors, that means SpaceX provides exposure to several businesses within a single publicly traded company.

For a closer look at the company and its listing, read why SpaceX (SPCX) is one of the most anticipated listings ever.

How it has performed: SPCX closed at $150.86 on September 30, up 11.75% from its $135 IPO price.

2. Quantinuum (QNT)

What it does: Quantinuum develops quantum computing hardware and software.

IPO date: June 4, 2026; Exchange: Nasdaq; IPO price: $60

Quantinuum became one of the most closely watched technology IPOs of 2026 when it listed on Nasdaq under QNT. The company develops quantum computing systems alongside software, developer tools and applications designed to make quantum computing useful for businesses and other organisations.

The company raised $1.68 billion in its IPO, giving it capital to continue developing its quantum computing technology and expanding its commercial operations.

How it has performed: QNT closed at $48.06 on September 30, down 19.90% from its $60 IPO price.

3. Bending Spoons (BSP)

What it does: Bending Spoons acquires and operates digital businesses and software products.

IPO date: July 1, 2026; Exchange: Nasdaq; IPO price: $29

Bending Spoons is an Italian technology company that built its business by acquiring and transforming digital products. Its portfolio includes businesses such as Vimeo, Brightcove and Eventbrite.

The IPO raised about $1.68 billion in total, with about $1 billion going to the company and the rest to existing shareholders who sold shares. It began trading on Nasdaq under BSP. Its approach is different from a traditional software company because acquisitions are a major part of its growth strategy.

How it has performed: BSP closed at $33.32 on September 30, up 14.90% from its $29 IPO price.

4. Jersey Mike's (JMKE)

What it does: Jersey Mike's is a US sandwich restaurant chain with company-owned and franchised locations.

IPO date: July 30, 2026. Exchange: New York Stock Exchange. IPO price: $23

Jersey Mike's joined the public markets in July, giving investors exposure to one of the largest sandwich franchise businesses in the US. The company priced its IPO at $23 per share and began trading on the NYSE under JMKE.

The company planned to use part of the IPO proceeds to repay debt, with the remainder available for general corporate purposes.

How it has performed: JMKE closed at $16.82 on September 30, down 26.87% from its $23 IPO price.

🔗Also read: 10 Stocks every beginner should know

5. Reformation (REF)

What it does: Reformation is a fashion brand focused on women's clothing and sustainability.

IPO date: July 30, 2026; Exchange: New York Stock Exchange; IPO price: $15

Los Angeles-area Reformation brought another consumer brand to the public markets in 2026. The company has built its brand around fashion, sustainability and digitally driven retail.

It priced its IPO at $15 per share and trades on the NYSE under REF.

The listing gives investors exposure to a consumer business rather than the technology and healthcare companies that have made up much of the year's IPO activity.

How it has performed: REF closed at $12.04 on September 30, down 19.73% from its $15 IPO price.

6. Scribe Therapeutics (SCTX)

What it does: Scribe Therapeutics develops genetic medicines using CRISPR-based technologies.

IPO date: July 24, 2026; Exchange: Nasdaq; IPO price: $15

Scribe Therapeutics is a clinical-stage biotechnology company developing genetic medicines designed to address the underlying causes of disease. Its pipeline includes programmes targeting cardiometabolic conditions.

The company priced its IPO at $15 per share and began trading on Nasdaq under SCTX in July. Like other early-stage biotechnology companies, much of its future depends on the progress of its drug development programmes and clinical trials.

How it has performed: SCTX closed at $18.41 on September 30, up 22.73% from its $15 IPO price.

7. ADARx Pharmaceuticals (ADRX)

What it does: ADARx Pharmaceuticals develops siRNA-based medicines for a range of diseases.

IPO date: September 25, 2026; Exchange: Nasdaq; IPO price: $17

ADARx is one of the newest biotechnology companies to join the US public markets. The San Diego-based company is developing RNA-based therapies, with clinical programmes targeting immune-related conditions, hereditary angioedema and blood-clotting disorders, and earlier-stage programmes in obesity and neurodegenerative diseases.

The company raised $446.3 million in its upsized IPO and began trading under ADRX on Nasdaq.

How it has performed: ADRX closed at $19.94 on September 30, up 17.29% from its $17 IPO price.

8. Fervo Energy (FRVO)

What it does: Fervo Energy develops geothermal energy technology.

IPO date: May 13, 2026; Exchange: Nasdaq; IPO price: $27

Fervo Energy brought geothermal power technology to the public markets in May. The company is developing enhanced geothermal systems designed to produce electricity using heat from beneath the Earth's surface.

Its IPO gives investors exposure to a different part of the energy market, particularly as demand grows for reliable electricity to support data centres and other energy-intensive infrastructure.

How it has performed: FRVO closed at $13.59 on September 30, down 49.67% from its $27 IPO price.

9. Cerebras Systems (CBRS)

What it does: Cerebras develops computing systems and processors designed for artificial intelligence workloads.

IPO date: May 14, 2026; Exchange: Nasdaq; IPO price: $185

Cerebras is an AI infrastructure company focused on the hardware required to run demanding artificial intelligence workloads. Its technology is designed to compete in a market that includes major semiconductor and computing companies.

The company's public listing gives investors another way to gain exposure to AI infrastructure growth without investing directly in an AI application or model developer.

How it has performed: CBRS closed at $177.65 on September 30, down 3.97% from its $185 IPO price.

10. Accelevation (ACCV)

What it does: Accelevation provides infrastructure products and services used in data centres and other industrial applications.

IPO date: September 30, 2026. Exchange: Nasdaq. IPO price: $18

Accelevation was one of the latest companies to join the US public markets in September. The company priced 30 million shares at $18 each and began trading on Nasdaq under ACCV on September 30.

Its business is closely tied to the infrastructure supporting data centre growth, including demand driven by artificial intelligence and other high-performance computing applications.

How it has performed: ACCV closed at $17.95 on its first trading day, down 0.28% from its $18 IPO price.

Upcoming IPOs to watch: OpenAI and Anthropic

Two of the year's most anticipated listings haven't happened yet. Both OpenAI and Anthropic have taken the first formal step towards going public, but neither has published a prospectus, set a price range or confirmed a listing date.

OpenAI

What it does: OpenAI develops AI models and products, including ChatGPT.

IPO status: Confidential draft filed with the SEC in June 2026. Expected timing: Not before 2027

OpenAI announced on June 8 that it had submitted a confidential S-1, the paperwork companies file with the US Securities and Exchange Commission (SEC) before going public. In March 2026, OpenAI was valued at $852 billion after raising $122 billion from investors.

Its listing has since been pushed back. In a September interview with Fortune, CEO Sam Altman ruled out an IPO this year, saying AI safety concerns made it the wrong moment to go public. Earlier reporting from The New York Times said OpenAI was aiming for a valuation of up to $1 trillion when it does list.

Anthropic

What it does: Anthropic develops AI models, including the Claude family of AI assistants.

IPO status: Confidential draft filed with the SEC on 1 June 2026. Expected timing: Reportedly November 2026. Expected exchange: Reportedly Nasdaq

Anthropic confidentially filed for its IPO a week before OpenAI, shortly after a funding round that valued the company at $965 billion. Business Insider has reported that it chose Nasdaq for its listing.

The listing was widely expected in October, but The Wall Street Journal reported on September 18 that Anthropic had moved its plans to November so it could present its third-quarter results to investors first. On October 1, Bloomberg reported that Anthropic could begin marketing its shares as soon as the week of November 9 and start trading before Thanksgiving on November 26. Prospective investors believe the IPO could value the company at $1.8 trillion to $2 trillion, making it the largest IPO on record.

Anthropic has not confirmed any of these dates or figures, and the timing could still change. If either company lists, check the Raenest app to see when you can buy its shares.

If you're choosing your first stock, read our guide on How to Pick Your First Stock for a closer look at what to consider before investing.

How to invest in new US IPO stocks from Nigeria

If you want an easy way to invest in these IPOs from Nigeria, Raenest makes it simple.

With Raenest, Nigerians can invest in 4,000+ US stocks and ETFs, with fractional shares available. This means you can invest a specific amount without needing enough money to purchase a full share. You can fund your Trading Wallet directly from your NGN, USD, GBP or EUR balance on Raenest, giving you flexibility over which balance you use to invest.

If you prefer to invest consistently, Raenest also offers Auto-Invest, which lets you automatically invest in US stocks on a weekly or monthly schedule. You can choose the stocks you want, set how much you want to invest and adjust, pause or cancel your plan when you need to.

To start investing, download the Raenest app, go to Stocks, search for the company you want to invest in, review the available information and place your order. Whether you're researching the latest IPOs in 2026, keeping an eye on upcoming listings like OpenAI and Anthropic, or building a portfolio of established US companies, Raenest gives you access to the US market from one app.

Open a Raenest account and start exploring US stocks and ETFs today.

‍

‍

‍

Disclaimer: Raenest is not a broker-dealer, investment adviser or member of FINRA. Securities are offered by Alpaca Securities LLC, a member of FINRA and SIPC. Raenest does not recommend any specific securities or investment strategies. Investing involves risk and investments may lose value, including the loss of principal. Past performance does not guarantee future results. Investors should consider their investment objectives and risks carefully before investing. US stock investments are held with Alpaca Securities LLC, a US-licensed broker-dealer regulated by the SEC and FINRA. Investment services are offered in partnership with City Investment Capital Limited, a firm licensed by the Securities and Exchange Commission of Nigeria.

‍